Phosphatidylinositol 3-kinase and p38 mitogen-activated protein kinase regulate induction of Mcl-1 and survival in glucocorticoid-treated human neutrophils

J Allergy Clin Immunol. 2008 Feb;121(2):492-498.e10. doi: 10.1016/j.jaci.2007.10.003. Epub 2007 Nov 26.

Abstract

Background: Glucocorticoids have been shown to inhibit human neutrophil apoptosis, with implications that this might help accentuate neutrophilic inflammation.

Objective: The aim of this study was to investigate the molecular mechanisms involved in glucocorticoid-mediated inhibition of primary human neutrophil apoptosis.

Methods: Primary human neutrophils were isolated from peripheral blood of healthy volunteers and cultured in vitro with dexamethasone.

Results: Here we confirm that dexamethasone, a classical glucocorticoid, significantly inhibited apoptosis of primary human neutrophils. This inhibition was not dependent on transrepression of proapoptotic molecules but was associated with induction of antiapoptotic Mcl-1. Remarkably, glucocorticoid-mediated enhancement of Mcl-1 and survival were significantly suppressed by pharmacologic inhibition of p38 mitogen-activated protein kinase or phosphatidylinositol 3-kinase. Inhibition of the above kinases also blocked glucocorticoid-induced maintenance of mitochondrial transmembrane potential and suppression of caspases.

Conclusion: Phosphatidylinositol 3-kinase and p38 mitogen-activated protein kinase are protein kinases that regulate the prosurvival effect of glucocorticoids on human neutrophils.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis / drug effects*
  • Apoptosis / physiology
  • Caspase Inhibitors
  • Cell Survival / drug effects
  • Cell Survival / physiology
  • Cells, Cultured
  • Dexamethasone / antagonists & inhibitors
  • Dexamethasone / pharmacology*
  • Glucocorticoids / antagonists & inhibitors
  • Glucocorticoids / pharmacology*
  • Granulocyte-Macrophage Colony-Stimulating Factor / pharmacology
  • Humans
  • Membrane Potential, Mitochondrial / drug effects
  • Myeloid Cell Leukemia Sequence 1 Protein
  • Neoplasm Proteins / biosynthesis*
  • Neoplasm Proteins / metabolism
  • Neutrophils / physiology*
  • Phosphatidylinositol 3-Kinases / metabolism*
  • Phosphoinositide-3 Kinase Inhibitors
  • Protein Kinase Inhibitors / pharmacology
  • Proto-Oncogene Proteins c-bcl-2 / biosynthesis*
  • Proto-Oncogene Proteins c-bcl-2 / metabolism
  • Signal Transduction / physiology
  • Up-Regulation
  • X-Linked Inhibitor of Apoptosis Protein / metabolism
  • p38 Mitogen-Activated Protein Kinases / antagonists & inhibitors
  • p38 Mitogen-Activated Protein Kinases / metabolism*

Substances

  • Caspase Inhibitors
  • Glucocorticoids
  • Myeloid Cell Leukemia Sequence 1 Protein
  • Neoplasm Proteins
  • Phosphoinositide-3 Kinase Inhibitors
  • Protein Kinase Inhibitors
  • Proto-Oncogene Proteins c-bcl-2
  • X-Linked Inhibitor of Apoptosis Protein
  • XIAP protein, human
  • Dexamethasone
  • Granulocyte-Macrophage Colony-Stimulating Factor
  • p38 Mitogen-Activated Protein Kinases